MitrAssist

Misgav Dov, Israel

MitrAssist offers a minimally invasive approach to mitral regurgitation treatment.

$100.0M raised

Sep 2023

Series C

Top Investors

Centurium CapitalCITIC Capital Holdings6 Dimensions CapitalFosun InternationalFosun Pharma

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has MitrAssist raised?

MitrAssist has raised $100.0M in total funding. The most recent round was Series C. The last funding was announced in September 2023.

Who are MitrAssist's investors?

MitrAssist's investors include Centurium Capital, CITIC Capital Holdings, 6 Dimensions Capital, Fosun International, Fosun Pharma.

Where is MitrAssist headquartered?

MitrAssist is headquartered in Misgav Dov, Israel.

What does MitrAssist do?

MitrAssist offers a minimally invasive approach to mitral regurgitation treatment.

What stage is MitrAssist at?

MitrAssist is at the Series C stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 26, 2023.

MLA

"MitrAssist — Funding & Investors." VCBacked, September 26, 2023, https://www.vcbacked.co/company/mitrassist. Accessed June 4, 2026.

APA

VCBacked. (2023). MitrAssist — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/mitrassist

Wikipedia (cite web)

{{cite web |title=MitrAssist — Funding & Investors |url=https://www.vcbacked.co/company/mitrassist |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 26, 2023.